Issue · Healthcare

Healthcare (Substance Abuse)

Every healthcare bill, vote, and legislator stance in New Hampshire, automatically classified by Maddy, our AI policy reader.

Total bills
1
2026 Regular Session
Top supporter
Bill Gannon
100% support rate
Top opponent
Cindy Rosenwald
0% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving substance abuse in New Hampshire

Legislators moving substance abuse in New Hampshire
Legislator Party Stance Support rate Decisive votes
Bill Gannon
Bill Gannon Senate · District 23
R
Strong +
100% 4
Dan Innis
Dan Innis Senate · District 7
R
Strong +
100% 4
Daryl Abbas
Daryl Abbas Senate · District 22
R
Strong +
100% 4
David Rochefort
David Rochefort Senate · District 1
R
Strong +
100% 4
Denise Ricciardi
Denise Ricciardi Senate · District 9
R
Strong +
100% 4
Cindy Rosenwald
Cindy Rosenwald Senate · District 13
D
Strong −
0% 4
David Watters
David Watters Senate · District 4
D
Strong −
0% 4
Debra Altschiller
Debra Altschiller Senate · District 24
D
Strong −
0% 4
Donovan Fenton
Donovan Fenton Senate · District 10
D
Strong −
0% 4
Pat Long
Pat Long Senate · District 20
D
Strong −
0% 4
Showing 1 of 1 bills

All healthcare bills

signed · New Hampshire · Senate May 29, 2026

SB 549: requiring certain syringe service program entities to provide options for disposal of used syringes and needles and creating reporting requirements for such entities.

SB 549 prohibits state and local governments from using public funds to support organizations that distribute drug paraphernalia, including needles and syringes through syringe service programs (SSPs). It specifically blocks state funds - such as those from opioid settlement money - from being used for SSPs that provide such paraphernalia, except during disease outbreak responses under existing law. The bill affects funding for public health programs by restricting how state and local resources can be allocated to organizations distributing drug-related items. The fiscal note indicates this would reduce annual funding for SSPs by approximately $1.7 million, though it clarifies this does not represent net savings but potential cost shifts to other healthcare services.